Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 3626 3681 3686 3783 3795
This examiner grants 48% of resolved cases
Michael Tomaszewski is an examiner in Tech Center 3700 and Art Unit 3626. The examiner has 595 resolved cases and an allowance rate of 47.9 percent. This 47.9 percent rate reflects the proportion of applications that successfully transition to granted patents. Practitioners should consider this rate when assessing the likelihood of a favorable outcome for their applications in Tech Center 3700.
The data reveals an interview lift of 22.2 percent. This 22.2 percent lift suggests that conducting an interview is associated with an increase in the probability of allowance compared to the baseline rate. For the 595 resolved cases, this metric indicates that direct engagement can be a useful strategy for overcoming prosecution hurdles. Practitioners may find this 22.2 percent lift to be a compelling reason to schedule formal discussions.
The median days to allowance is 1190. This 1190-day duration is the middle value for the time required to reach a grant. This timeframe provides a benchmark for the expected length of the prosecution process from filing to issuance. By considering the 1190-day median alongside the 47.9 percent allowance rate, applicants can better estimate both the timing and the probability of success.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18450934 | LEFT ATRIAL APPENDAGE CLOSURE PRE-PROCEDURE SYSTEM AND METHODS | Non-Final OA | BOSTON SCIENTIFIC SCIMED, INC. |
| 18564695 | STRESSOR ESTIMATION DEVICE, STRESSOR ESTIMATION METHOD, AND STORAGE MEDIUM | Non-Final OA | NEC Corporation |
| 18810036 | ADAPTIVE INTERACTION BETWEEN SMART HEALTHCARE SYSTEMS | Final Rejection | Cilag GmbH International |
| 18857430 | Computing Device Having a Button for Multiple Modes of Sensing | Final Rejection | Google LLC |
| 18986341 | BED HAVING FEATURES FOR DETERMINING RISK OF CARDIAC CONDITIONS INCLUDING ATRIAL FIBRILLATION | Non-Final OA | SNBR INC |
| 18772453 | VENDOR NEUTRAL ARTIFICIAL INTELLIGENCE INFUSED PROTOCOL CREATION AND OPTIMIZATION | Final Rejection | GE Precision Healthcare LLC |
| 18805891 | ASSESSING CARDIAC RISK | Non-Final OA | ZOLL Medical Corporation |
| 18558275 | SYSTEMS AND METHODS FOR IDENTIFYING NOVEL PORE-FORMING TOXINS | Non-Final OA | University of Southern California |
| 17816001 | SYSTEM AND METHOD FOR ESTIMATING A RESERVOIR VOLUME OF AN IMPLANTABLE MEDICAL DEVICE | Non-Final OA | Medtronic, Inc. |
| 18486270 | COMPUTER IMPLEMENTED TECHNIQUES FOR SAMPLE OPTIMIZATION | Final Rejection | Optum Services (Ireland) Limited |
| 18406868 | CLINICAL SYSTEM INTEGRATION | Final Rejection | United States Government as Represented by the Department of Veterans Affairs |
| 18561587 | SYSTEMS AND METHODS FOR ASSESSING GASTROINTESTINAL CLEANSING | Final Rejection | Given Imaging LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy